Warner BM, Vendramelli R, Boese AS, Audet J, et al. Treatment with the CCR5 antagonist OB-002 reduces lung pathology, but does not prevent disease in a Syrian hamster model of SARS-CoV-2 infection. PLoS One 2025;20:e0316952.
PMID: 39908288